Daviskas E, Anderson S D, Eberl S, Chan H K, Young I H, Seale J P
Dept of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Eur Respir J. 2002 Dec;20(6):1423-9. doi: 10.1183/09031936.02.00301502.
Beta2-agonists and osmotic agents stimulate mucociliary clearance (MCC) via different mechanisms which could potentially interact. The effects of inhaling terbutaline in combination with mannitol on MCC were investigated in nine healthy (aged 19+/-1 yrs) and 11 mild (aged 21+/-4 yrs) asthmatic subjects. Using 99mTc-sulphur colloid radioaerosol and a gamma camera, MCC was studied on four separate days with each of the following interventions: 1) terbutaline or its placebo inhaled 10 min before mannitol (in random, double blind); 2) terbutaline inhaled 5 min after mannitol; and 3) terbutaline inhaled 10 min before the control for mannitol. Lung images were collected over a period of 120 min postintervention and over 150 min in total. The mannitol-induced increase in clearance was transiently inhibited by terbutaline pretreatment and transiently enhanced when terbutaline was administered after mannitol both in asthmatic and healthy subjects. The order of administration of mannitol and terbutaline did not affect the total clearance of radioactive mucus over 140 min from the start of intervention in both groups. The pathways through which terbutaline and mannitol increase mucociliary clearance may transiently interact in an inhibitory or synergistic way, depending on the order of administration. However, this did not affect the overall increase in mucociliary clearance over 140 min.
β2激动剂和渗透剂通过不同机制刺激黏液纤毛清除(MCC),这些机制可能存在相互作用。我们在9名健康受试者(年龄19±1岁)和11名轻度哮喘受试者(年龄21±4岁)中研究了吸入特布他林联合甘露醇对MCC的影响。使用99mTc-硫胶体放射性气溶胶和γ相机,在4个不同日期对以下每种干预措施进行MCC研究:1)在甘露醇吸入前10分钟吸入特布他林或其安慰剂(随机、双盲);2)在甘露醇吸入后5分钟吸入特布他林;3)在甘露醇对照前10分钟吸入特布他林。干预后120分钟内收集肺部图像,总共收集150分钟。在哮喘患者和健康受试者中,特布他林预处理可短暂抑制甘露醇诱导的清除增加,而在甘露醇吸入后给予特布他林则可短暂增强清除。在两组中,甘露醇和特布他林的给药顺序不影响从干预开始140分钟内放射性黏液的总清除率。特布他林和甘露醇增加黏液纤毛清除的途径可能根据给药顺序以抑制或协同的方式短暂相互作用。然而,这并不影响140分钟内黏液纤毛清除的总体增加。